Company Monitoring Page for Cellectis

latest headlines for company on cafepharma

AstraZeneca Drops $245M on Cell and Gene Therapies in Deal with Cellectis
BioSpace
Wed, 11/1/23 - 11:07 am
Tags:
AstraZeneca, Cellectis, cell therapy, gene therapy
SITC: Cellectis' off-the-shelf CAR-T for pancreatic cancer and mesothelioma shows activity in mice
Fierce Biotech
Fri, 11/12/21 - 11:41 am
Tags:
Cellectis, CAR-T, cancer, pancreatic cancer, mesothelioma, SITC
Sanofi, Cellectis team up to pair Lemtrada with allogeneic CAR-Ts; Bristol Myers joins Evotec's drive to advance UK science
Endpoints
Thu, 05/13/21 - 11:59 pm
Tags:
Sanofi, Cellectis, allogeneic cells, CAR-T, alemtuzumab, Lemtrada
FDA gives Cellectis all clear after patient death halted off-the-shelf CAR-T trial
Endpoints
Wed, 11/18/20 - 11:03 am
Tags:
Cellectis, FDA, patient deaths, CAR-T, clinical trials, Multiple Myeloma
Death in Cellectis off-the-shelf CAR-T trial triggers FDA hold
Fierce Biotech
Tue, 07/7/20 - 10:39 am
Tags:
Cellectis, CAR-T, UCARCS1A, Multiple Myeloma, patient deaths, FDA
Cellectis boosts its coffers in revised off-the-shelf CAR-T deal with Servier
Endpoints
Wed, 02/19/20 - 09:56 am
Tags:
CAR-T, Cellectis, Servier, UCART19
Cellectis gene editing patent upheld in Europe
Seeking Alpha
Thu, 11/21/19 - 10:31 am
Tags:
gene editing, Europe, Cellectis, patents
FDA lifts hold on Cellectis’ CAR-T trial, adds go-slow caveat
Fierce Biotech
Tue, 11/7/17 - 09:38 am
Tags:
FDA, Cellectis, CAR-T, clinical trials, UCART123
New Guidelines Address CAR-T Immunotherapy Toxicities to Prevent Patient Deaths
Xtalks
Wed, 09/20/17 - 10:41 am
Tags:
CAR-T, Juno Therapeutics, Kite Pharma, Cellectis
Patient Death Triggers FDA Hold For Cellectis’s “Off the Shelf” CAR-T
Xconomy
Tue, 09/5/17 - 09:50 am
Tags:
FDA, Cellectis, CAR-T, UCART123, clinical trials
Medivir out-licenses hep C drug to China’s Ascletis; Cellectis launches pioneering UCART123 US study
Endpoints
Sat, 08/19/17 - 10:29 am
Tags:
Medvir, hepatitis C, China, Ascletis, Cellectis, UCART123, CAR-T
Servier, Pfizer get FDA OK to start US testing of an off-the-shelf CAR-T from Cellectis
Endpoints
Thu, 03/9/17 - 11:34 am
Tags:
Pfizer, Servier, FDA, CAR-T, UCART19, Cellectis, acute lymphocytic leukemia
Pfizer snags U.S. rights to Cellectis' white-hot CAR-T therapy
Fierce Biotech
Fri, 11/20/15 - 11:03 am
Tags:
Pfizer, Cellectis, CAR-T, immuno-oncology
Cellectis makes history as CAR-T therapy clears terminal leukemia in baby girl
BioPharma Dive
Fri, 11/6/15 - 03:39 pm
Tags:
Cellectis, CAR-T, UCART19
Buzz: Cellectis could be in line for a $1.6B Pfizer buyout
Fierce Biotech
Thu, 05/28/15 - 07:20 pm
Tags:
Cellectis, Pfizer, M&A
Cellectis upscales IPO toward $200M as CAR-T fever continues
Fierce Biotech
Wed, 03/25/15 - 09:45 am
Tags:
Cellectis, IPOs, CAR-T
Safety concerns cloud early promise of powerful new cancer drugs
Yahoo/Reuters
Mon, 01/26/15 - 08:12 am
Tags:
cancer, CAR-T, Amgen, Celgene, Bluebird Bio, Novartis, Kite Pharma, Pfizer, Cellectis, Juno Therapeutics
Cellectis Is Late To The CAR-T Cell Race, But Could Finish First
Seeking Alpha
Fri, 01/2/15 - 07:33 pm
Tags:
Cellectis, CAR-T, Novartis, GSK, Bellicum, Celgene, Bluebird Bio
Pfizer: Struggling Through A Tough Time
Seeking Alpha
Wed, 07/16/14 - 08:58 am
Tags:
Pfizer, China, Viagra, patents, Cellectis, oncology
Pfizer's Plan B In Immuno-Oncology: Collaboration With Smaller Companies
Seeking Alpha
Wed, 06/25/14 - 05:16 pm
Tags:
Pfizer, cancer immunotherapy, Cellectis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.